Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 47

References for PMC Articles for PubMed (Select 19776383)


Regulatory T-cell depletion does not prevent emergence of new CD25+ FOXP3+ lymphocytes after antigen stimulation in culture.

Melenhorst JJ, Scheinberg P, Lu J, Ambrozak DR, Sosa E, Zhao L, Hensel NF, Savani BN, Douek DC, Price DA, Barrett AJ.

Cytotherapy. 2008;10(2):152-64. doi: 10.1080/14653240701853536.


Induction and evolution of cytomegalovirus-specific CD4+ T cell clonotypes in rhesus macaques.

Price DA, Bitmansour AD, Edgar JB, Walker JM, Axthelm MK, Douek DC, Picker LJ.

J Immunol. 2008 Jan 1;180(1):269-80.


Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates.

Berger C, Jensen MC, Lansdorp PM, Gough M, Elliott C, Riddell SR.

J Clin Invest. 2008 Jan;118(1):294-305.


The clonal composition of human CD4+CD25+Foxp3+ cells determined by a comprehensive DNA-based multiplex PCR for TCRB gene rearrangements.

Scheinberg P, Melenhorst JJ, Hill BJ, Keyvanfar K, Barrett AJ, Price DA, Douek DC.

J Immunol Methods. 2007 Apr 10;321(1-2):107-20. Epub 2007 Feb 2.


Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation.

Casazza JP, Betts MR, Price DA, Precopio ML, Ruff LE, Brenchley JM, Hill BJ, Roederer M, Douek DC, Koup RA.

J Exp Med. 2006 Dec 25;203(13):2865-77. Epub 2006 Dec 11.


Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia.

Scheinberg P, Fischer SH, Li L, Nunez O, Wu CO, Sloand EM, Cohen JI, Young NS, John Barrett A.

Blood. 2007 Apr 15;109(8):3219-24. Epub 2006 Dec 5.


Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection.

Makedonas G, Betts MR.

Springer Semin Immunopathol. 2006 Nov;28(3):209-19. Epub 2006 Aug 25. Review. No abstract available.


Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses.

Price DA, Brenchley JM, Ruff LE, Betts MR, Hill BJ, Roederer M, Koup RA, Migueles SA, Gostick E, Wooldridge L, Sewell AK, Connors M, Douek DC.

J Exp Med. 2005 Nov 21;202(10):1349-61. Epub 2005 Nov 14.


Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects.

Sylwester AW, Mitchell BL, Edgar JB, Taormina C, Pelte C, Ruchti F, Sleath PR, Grabstein KH, Hosken NA, Kern F, Nelson JA, Picker LJ.

J Exp Med. 2005 Sep 5;202(5):673-85.


Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers.

Cobbold M, Khan N, Pourgheysari B, Tauro S, McDonald D, Osman H, Assenmacher M, Billingham L, Steward C, Crawley C, Olavarria E, Goldman J, Chakraverty R, Mahendra P, Craddock C, Moss PA.

J Exp Med. 2005 Aug 1;202(3):379-86.


Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells.

Klebanoff CA, Gattinoni L, Torabi-Parizi P, Kerstann K, Cardones AR, Finkelstein SE, Palmer DC, Antony PA, Hwang ST, Rosenberg SA, Waldmann TA, Restifo NP.

Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9571-6. Epub 2005 Jun 24.


Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.

Dudley ME, Wunderlich JR, Yang JC, Sherry RM, Topalian SL, Restifo NP, Royal RE, Kammula U, White DE, Mavroukakis SA, Rogers LJ, Gracia GJ, Jones SA, Mangiameli DP, Pelletier MM, Gea-Banacloche J, Robinson MR, Berman DM, Filie AC, Abati A, Rosenberg SA.

J Clin Oncol. 2005 Apr 1;23(10):2346-57.


Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease.

Bollard CM, Aguilar L, Straathof KC, Gahn B, Huls MH, Rousseau A, Sixbey J, Gresik MV, Carrum G, Hudson M, Dilloo D, Gee A, Brenner MK, Rooney CM, Heslop HE.

J Exp Med. 2004 Dec 20;200(12):1623-33.


T cell receptor recognition motifs govern immune escape patterns in acute SIV infection.

Price DA, West SM, Betts MR, Ruff LE, Brenchley JM, Ambrozak DR, Edghill-Smith Y, Kuroda MJ, Bogdan D, Kunstman K, Letvin NL, Franchini G, Wolinsky SM, Koup RA, Douek DC.

Immunity. 2004 Dec;21(6):793-803.


Assessment of cellular immunity to human cytomegalovirus in recipients of allogeneic stem cell transplants.

Lacey SF, Diamond DJ, Zaia JA.

Biol Blood Marrow Transplant. 2004 Jul;10(7):433-47. Review.


Central memory and effector memory T cell subsets: function, generation, and maintenance.

Sallusto F, Geginat J, Lanzavecchia A.

Annu Rev Immunol. 2004;22:745-63. Review.


IMGT, The International ImMunoGeneTics Information System,

Lefranc MP.

Methods Mol Biol. 2004;248:27-49. No abstract available.


Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines.

Peggs KS, Verfuerth S, Pizzey A, Khan N, Guiver M, Moss PA, Mackinnon S.

Lancet. 2003 Oct 25;362(9393):1375-7.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk